Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolv Technologies Holdings, Inc.EVLV · Entity 5017 | Founder & Chief Growth Officer | March 01, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolv Technologies Holdings, Inc.
Report date March 01, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,348,651 |
Ending reported balance
After 2026-03-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-01 · Exercise / conversion · Acquired 53,430 · Balance 1,328,530 Row 2 · 2026-03-01 · Exercise / conversion · Acquired 45,913 · Balance 1,374,443 Row 3 · 2026-03-01 · Exercise / conversion · Acquired 37,878 · Balance 1,412,321 Row 4 · 2026-03-02 · Sale · Disposed 63,670 · Balance 1,348,651 F1: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.30. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-01 · Exercise / conversion · Disposed 53,430 · Balance 0 F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F4: The RSUs vest in three equal annual installments commencing on March 1, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 45,915 |
Reported balance
After 2026-03-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-01 · Exercise / conversion · Disposed 45,913 · Balance 45,915 F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F5: The RSUs vest in three equal annual installments commencing on March 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 75,758 |
Reported balance
After 2026-03-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-01 · Exercise / conversion · Disposed 37,878 · Balance 75,758 F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F6: The RSUs vest in three equal annual installments commencing on March 1, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 46,728 |
Reported balance
After 2026-03-02 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-03-02 · Grant · Acquired 46,728 · Balance 46,728 F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F7: The RSUs vest in three equal annual installments commencing on March 2, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.30. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date.
F4: The RSUs vest in three equal annual installments commencing on March 1, 2024.
F5: The RSUs vest in three equal annual installments commencing on March 1, 2025.
F6: The RSUs vest in three equal annual installments commencing on March 1, 2026.
F7: The RSUs vest in three equal annual installments commencing on March 2, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 22:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 47,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006337 · wf-form4_167788168016791.xml · derivative · entry 3 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,516 Underlying: Class A Common Stock · 47,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2023. F2 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 47,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006337 · wf-form4_167788168016791.xml · nonDerivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,145,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 22:54 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001628280-23-001763 · wf-form4_167511922038410.xml · derivative · entry 3 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,159,078 Underlying: Class A Common Stock · 50,000 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 22:54 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 50,000 | $3.00 | $150,000.00 |
DisclosureSEC source: 0001628280-23-001763 · wf-form4_167511922038410.xml · nonDerivative · entry 2 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097,972 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 15, 2022. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 22:54 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 50,000 | $0.24 | $12,000.00 |
DisclosureSEC source: 0001628280-23-001763 · wf-form4_167511922038410.xml · nonDerivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,147,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:31 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 963 | $2.37 | $2,282.31 |
DisclosureSEC source: 0001628280-23-000780 · wf-form4_167330710478154.xml · nonDerivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097,972 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.37 to $2.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 01:23 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000358 · wf-form4_167288181251980.xml · derivative · entry 2 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Class A Common Stock · 2,500 shares Expires not disclosed F1 · derivative.exercise_price: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · shares: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.exercise_date: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.expiration_date: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 01:23 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantClass A Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000358 · wf-form4_167288181251980.xml · nonDerivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098,935 F1 · shares: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:24 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 151 | $2.10 | $317.10 |
DisclosureSEC source: 0001104659-22-102690 · tm2226581-1_4seq1.xml · nonDerivative · entry 2 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,435 F2 · kind: The sale reported in the Form 4 was effected pursuant to a standing Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.13. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:24 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-102690 · tm2226581-1_4seq1.xml · derivative · entry 3 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.exercise_date: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.expiration_date: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:24 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-102690 · tm2226581-1_4seq1.xml · nonDerivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:14 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 215,517 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001104659-22-030224 · tm228072-3_4seq1.xml · derivative · entry 2 Chitkara Anil · CIK 0001870900 · Founder & Head of Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,517 Underlying: Class A Common Stock · 215,517 shares Expires 2032-02-29 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:14 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 143,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-030224 · tm228072-3_4seq1.xml · derivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Head of Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,266 Underlying: Class A Common Stock · 143,266 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2023. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2022 Filed Sep 16, 2022 00:35 UTC Amendment | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 215,517 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001628280-22-025043 · wf-form4a_166328852348440.xml · derivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Chief Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,517 Underlying: Class A Common Stock · 215,517 shares Expires 2032-02-29 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter. Read SEC document |
| September 27, 2021 Filed Sep 28, 2021 20:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-120234 · tm2128583-1_4seq1.xml · derivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Head of Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Class A Common Stock · 500 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantPerformance Rights · Derivative | 353,513 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094053 · tm2122604-4_4seq1.xml · derivative · entry 5 Chitkara Anil · CIK 0001870900 · Founder & Head of Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,513 Underlying: Class A Common Stock · 353,513 shares Expires not disclosed F5 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F5 · price: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F5 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F5 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 661,214 | Not disclosed Strike: $0.42 | Not disclosed |
DisclosureSEC source: 0001104659-21-094053 · tm2122604-4_4seq1.xml · derivative · entry 4 Chitkara Anil · CIK 0001870900 · Founder & Head of Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 661,214 Underlying: Class A Common Stock · 661,214 shares Expires 2031-01-10 F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F1 · price: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F4 · derivative.exercise_date: The option vests and becomes exercisable as to 25% on January 1, 2022 and will vest in 36 equal monthly installments thereafter. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 14,169 | Not disclosed Strike: $0.42 | Not disclosed |
DisclosureSEC source: 0001104659-21-094053 · tm2122604-4_4seq1.xml · derivative · entry 3 Chitkara Anil · CIK 0001870900 · Founder & Head of Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,169 Underlying: Class A Common Stock · 14,169 shares Expires 2030-08-17 F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F1 · price: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% on June 3, 2021 and will vest in 36 equal monthly installments thereafter. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 1,209,078 | Not disclosed Strike: $0.24 | Not disclosed |
DisclosureSEC source: 0001104659-21-094053 · tm2122604-4_4seq1.xml · derivative · entry 2 Chitkara Anil · CIK 0001870900 · Founder & Head of Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,209,078 Underlying: Class A Common Stock · 1,209,078 shares Expires 2027-09-13 F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F1 · price: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantClass A Common Stock | 1,096,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094053 · tm2122604-4_4seq1.xml · nonDerivative · entry 1 Chitkara Anil · CIK 0001870900 · Founder & Head of Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,086 F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F1 · price: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.